Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$194M |
| 2 |
Oracle
ORCL
|
+$159M |
| 3 |
AutoZone
AZO
|
+$159M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$157M |
| 5 |
Merck
MRK
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$881M |
| 2 |
Blackstone
BX
|
+$367M |
| 3 |
Toronto Dominion Bank
TD
|
+$297M |
| 4 |
Scotiabank
BNS
|
+$264M |
| 5 |
Netflix
NFLX
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.8% |
| 2 | Miscellaneous | 15.16% |
| 3 | Technology | 10.24% |
| 4 | Energy | 8.8% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
National Healthcare
NHC
$3.57B
| $308K | ﹤0.01% |
3,796
+1,068
| +39% | +$82.4K |
2013 Q2
24 quarters
|
|
|
TUP
2702
DELISTED
Tupperware Brands Corporation
TUP
| $308K | ﹤0.01% |
16,213
+3,040
| +23% | +$68.3K |
2013 Q2
24 quarters
|
|
2703
ESCO Technologies
ESE
$7.12B
| $307K | ﹤0.01% |
3,712
+2,439
| +192% | +$179K |
2015 Q2
16 quarters
|
|
|
GBT
2704
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $307K | ﹤0.01% |
5,841
+4,966
| +568% | +$285K |
2017 Q1
9 quarters
|
|
2705
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$4.02B
| $305K | ﹤0.01% |
4,374
+74
| +2% | +$5.14K |
2016 Q3
11 quarters
|
|
2706
Freshpet
FRPT
$2.9B
| $301K | ﹤0.01% |
6,621
+2,266
| +52% | +$103K |
2016 Q1
13 quarters
|
|
|
AVX
2707
DELISTED
AVX Corporation
AVX
| $301K | ﹤0.01% |
18,131
+17,218
| +1,886% | +$283K |
2014 Q3
19 quarters
|
|
|
BID
2708
DELISTED
Sotheby's
BID
| $301K | ﹤0.01% |
5,167
-144,203
| -97% | -$6.02M |
2013 Q2
24 quarters
|
|
2709
Simmons First National
SFNC
$3.31B
| $300K | ﹤0.01% |
12,871
+7,393
| +135% | +$180K |
2015 Q1
17 quarters
|
|
|
WBS
2710
DELISTED
Webster Financial
WBS
| $300K | ﹤0.01% |
6,284
-4,469
| -42% | -$223K |
2013 Q2
24 quarters
|
|
2711
Guardant Health
GH
$23.9B
| $299K | ﹤0.01% |
+3,457
| New | +$264K |
2019 Q2
0 quarters
|
|
|
AVNS
2712
DELISTED
Avanos Medical
AVNS
| $297K | ﹤0.01% |
6,801
+3,858
| +131% | +$165K |
2015 Q1
17 quarters
|
|
2713
Northern Oil and Gas
NOG
$2.54B
| $297K | ﹤0.01% |
+15,420
| New | +$357K |
2019 Q2
0 quarters
|
|
2714
8x8 Inc
EGHT
$329M
| $296K | ﹤0.01% |
12,285
+8,240
| +204% | +$192K |
2013 Q2
24 quarters
|
|
2715
First Trust Technology AlphaDEX Fund
FXL
$2.93B
| $296K | ﹤0.01% |
4,445
-300
| -6% | -$19.6K |
2015 Q1
17 quarters
|
|
2716
PUT
TherapeuticsMD
TXMD
$23.7M
| $296K | ﹤0.01% |
+2,280
| New | +$409K |
2019 Q2
0 quarters
|
|
|
MTOR
2717
DELISTED
MERITOR, Inc.
MTOR
| $296K | ﹤0.01% |
12,232
+4,278
| +54% | +$96.1K |
2013 Q2
24 quarters
|
|
2718
Aaon
AAON
$6.87B
| $295K | ﹤0.01% |
8,823
+5,652
| +178% | +$179K |
2013 Q2
24 quarters
|
|
2719
Cirrus Logic
CRUS
$6.07B
| $295K | ﹤0.01% |
6,754
+4,920
| +268% | +$214K |
2013 Q2
24 quarters
|
|
|
BKI
2720
DELISTED
Black Knight, Inc. Common Stock
BKI
| $295K | ﹤0.01% |
4,909
-9,592
| -66% | -$545K |
2016 Q1
13 quarters
|
|
2721
Invesco Mortgage Capital
IVR
$622M
| $294K | ﹤0.01% |
1,827
+1,058
| +138% | +$170K |
2013 Q2
24 quarters
|
|
2722
Iovance Biotherapeutics
IOVA
$6.44B
| $293K | ﹤0.01% |
11,937
+9,599
| +411% | +$145K |
2015 Q4
14 quarters
|
|
2723
PUT
Village Farms International
VFF
$347M
| $292K | ﹤0.01% |
+25,500
| New | +$323K |
2019 Q2
0 quarters
|
|
2724
Washington Trust Bancorp
WASH
$734M
| $292K | ﹤0.01% |
5,589
+1,275
| +30% | +$64.8K |
2013 Q2
24 quarters
|
|
|
BBBY
2725
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $292K | ﹤0.01% |
+25,100
| New | +$372K |
2019 Q2
0 quarters
|
|
Similar funds
Bank of Montreal's Q2 2019 Portfolio in Review
As of Q2 2019, Bank of Montreal held 5,259 positions worth $119B, up 1.9% from $117B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of Montreal's Q2 2019 filing shows 822 new, 2,226 increased, 1,465 reduced and 324 closed positions. Its largest new stake was Dow Inc: 1,346,158 shares worth $66.4M. The largest sale was Apple, an estimated $881M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Technology.
- Bank of Montreal's largest Q2 2019 buy was Dow Inc: 1,346,158 shares worth $66.4M.
- Bank of Montreal added most to Mastercard in Q2 2019, an estimated $194M increase.
- Bank of Montreal's biggest Q2 2019 reduction was Apple, cutting an estimated $881M.
- Bank of Montreal fully exited Goldcorp Inc in Q2 2019, selling an estimated $93M.
- Bank of Montreal's ten largest holdings make up 22% of its $119B portfolio in Q2 2019.
- Bank of Montreal opened 822 new positions and closed 324 in Q2 2019.
- Bank of Montreal's portfolio value rose 1.9% quarter-over-quarter to $119B.
Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.